Prosecution Insights
Last updated: April 19, 2026

Shanghai Huayu Biotechnology Co. Lts

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17786073 COMBINATION CANCER THERAPY USING CHK INHIBITOR BURKETT, DANIEL JOHN 1624 Final Rejection Jun 16, 2022

Managing Shanghai Huayu Biotechnology Co. Lts's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month